Learn / DSGN
NASDAQ: DSGN
Design Therapeutics (DSGN) stock, explained like you're 5
Design Therapeutics trades on the Nasdaq under the ticker DSGN. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 729 million dollars.
- Ticker
- DSGN
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 729 million dollars
Is Design Therapeutics a small, medium or large cap company?
No. Design Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 729 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Design Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves DSGN stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth (Simply Wall Street)
- DSGN Oct 2026 11.000 call (DSGN261016C00011000) stock historical prices and data (Yahoo Finance UK)
- Design Therapeutics: 'Hold' DT 216P2 Registrational FA Plans Q4 2026 And 12 Week Results Q1 2027 (Seeking Alpha)
- Design Therapeutics Stock Wobbles After Rare Genetic Disease Data Design Therapeutics (NASDAQ:DSGN) (Benzinga)
- Liquidity Mapping Around (DSGN) Price Events (Stock Traders Daily)
Follow DSGN in your daily brief
Each trading day at 5 PM ET we post what happened to Design Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow DSGN
Questions about Design Therapeutics stock
What does Design Therapeutics do?
Design Therapeutics trades on the Nasdaq under the ticker DSGN. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 729 million dollars.
What is the ticker symbol for Design Therapeutics?
Design Therapeutics trades under the ticker DSGN on the Nasdaq.
What is Design Therapeutics's market cap?
Design Therapeutics is a small cap stock with a market cap of about 729 million dollars.
How does Design Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves DSGN stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow DSGN stock every day?
Add DSGN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.